| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $5.63B | +15.2% |
| R&D Expense | $188.8M | +2.3% |
| SG&A Expense | $165.2M | +31.4% |
| Operating Income | -$154.8M | +50.8% |
| Pre-tax Income | -$154.9M | +51.8% |
| Income Tax | -$500K | -25.0% |
| Net Income | -$154.4M | +51.9% |
| EPS (Basic) | -$0.31 | +55.1% |
| EPS (Diluted) | -$0.31 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $223.8M | +34.1% |
| Accounts Receivable | $48.6M | +32.8% |
| Current Assets | $330.0M | +17.0% |
| Total Assets | $1.18B | +1.5% |
| Current Liabilities | $353.2M | +20.8% |
| Total Liabilities | $765.6M | +5.1% |
| Stockholders' Equity | $409.4M | -4.5% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $121.5M | +569.1% |
| Capital Expenditures | $15.7M | +40.2% |
| Investing Cash Flow | -$36.6M | -212.8% |
| Financing Cash Flow | -$28.0M | +82.2% |
| Free Cash Flow | $105.8M | +385.2% |
| +55.1% |